These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16195905)

  • 1. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients.
    Normand S; François B; Dardé ML; Bouteille B; Bonnivard M; Preux PM; Gastinne H; Vignon P
    Intensive Care Med; 2005 Nov; 31(11):1508-13. PubMed ID: 16195905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida spp. colonization significance in critically ill medical patients: a prospective study.
    Charles PE; Dalle F; Aube H; Doise JM; Quenot JP; Aho LS; Chavanet P; Blettery B
    Intensive Care Med; 2005 Mar; 31(3):393-400. PubMed ID: 15711782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial.
    Giglio M; Caggiano G; Dalfino L; Brienza N; Alicino I; Sgobio A; Favale A; Coretti C; Montagna MT; Bruno F; Puntillo F
    Crit Care; 2012 Dec; 16(2):R57. PubMed ID: 22490643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.
    Ferreira D; Grenouillet F; Blasco G; Samain E; Hénon T; Dussaucy A; Millon L; Mercier M; Pili-Floury S
    Intensive Care Med; 2015 Jun; 41(6):1077-88. PubMed ID: 25894623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical research of nystatin in prevention of invasive fungal infections in patients on mechanical ventilation in intensive care unit].
    Chen Z; Yang CL; He HW; Zeng J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):475-8. PubMed ID: 24021043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed?
    Eggimann P; Wolff M; Garbino J
    Intensive Care Med; 2005 Nov; 31(11):1466-8. PubMed ID: 16195906
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.
    Lumbreras C; Cuervas-Mons V; Jara P; del Palacio A; Turrión VS; Barrios C; Moreno E; Noriega AR; Paya CV
    J Infect Dis; 1996 Sep; 174(3):583-8. PubMed ID: 8769617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation.
    Russo A; Carriero G; Farcomeni A; Ceccarelli G; Tritapepe L; Venditti M
    Mycoses; 2017 Dec; 60(12):826-829. PubMed ID: 28877374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.
    Garbino J; Lew DP; Romand JA; Hugonnet S; Auckenthaler R; Pittet D
    Intensive Care Med; 2002 Dec; 28(12):1708-17. PubMed ID: 12447512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis.
    Epstein JB; Hancock PJ; Nantel S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Aug; 96(2):154-63. PubMed ID: 12931087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of Candida colonization and Candida infection in the critically ill patient.
    Olaechea PM; Palomar M; León-Gil C; Alvarez-Lerma F; Jordá R; Nolla-Salas J; León-Regidor MA;
    Eur J Clin Microbiol Infect Dis; 2004 Apr; 23(4):323-30. PubMed ID: 15024623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients.
    Savino JA; Agarwal N; Wry P; Policastro A; Cerabona T; Austria L
    J Trauma; 1994 Jan; 36(1):20-5; discussion 25-6. PubMed ID: 8295245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of fluconazole administration on outcomes in critically ill patients.
    Garrelts JC; Schroeder TR; Harrison PB
    Ann Pharmacother; 2004 Oct; 38(10):1588-92. PubMed ID: 15340132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants.
    Oncel MY; Arayici S; Sari FN; Simsek GK; Yurttutan S; Erdeve O; Saygan S; Uras N; Oguz SS; Dilmen U
    J Matern Fetal Neonatal Med; 2015; 28(15):1790-4. PubMed ID: 25245226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.
    Playford EG; Lipman J; Jones M; Lau AF; Kabir M; Chen SC; Marriott DJ; Seppelt I; Gottlieb T; Cheung W; Iredell JR; McBryde ES; Sorrell TC
    Clin Infect Dis; 2016 Dec; 63(11):1463-1469. PubMed ID: 27601224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral nystatin prophylaxis and neonatal fungal infections.
    Howell A; Isaacs D; Halliday R;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F429-33. PubMed ID: 19321509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical Nystatin for the Prevention of Catheter-Associated Candidiasis in ELBW Infants.
    Bodin MB; Godoy G; Philips JB
    Adv Neonatal Care; 2015 Jun; 15(3):220-4. PubMed ID: 25938952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.